Yogesh Dwivedi

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 20

Top Topics

Prefrontal Cortex

Dna Methylation

Top Venues

Molecular psychiatry

International journal of molecular sciences

Molecular neurobiology

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Bhaskar Roy, Shinichiro Ochi, Yogesh Dwivedi
Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior. International journal of molecular sciences 24 (5) (2023)
Shinichiro Ochi, Bhaskar Roy, Kevin Prall, Richard C Shelton, Yogesh Dwivedi
Strong associations of telomere length and mitochondrial copy number with suicidality and abuse history in adolescent depressed individuals. Molecular psychiatry (2023)
Bhaskar Roy, Shinichiro Ochi, Yogesh Dwivedi
Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior. International journal of molecular sciences 24 (5) (2023)
Bhaskar Roy, Shinichiro Ochi, Yogesh Dwivedi
Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior. International journal of molecular sciences 24 (5) (2023)
Bhaskar Roy, Shinichiro Ochi, Yogesh Dwivedi
Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior. International journal of molecular sciences 24 (5) (2023)
Shinichiro Ochi, Yogesh Dwivedi
Dissecting early life stress-induced adolescent depression through epigenomic approach. Molecular psychiatry 28 (1) (2022)
Shinichiro Ochi, Yogesh Dwivedi
Dissecting early life stress-induced adolescent depression through epigenomic approach. Molecular psychiatry 28 (1) (2022)
Shinichiro Ochi, Yogesh Dwivedi
Dissecting early life stress-induced adolescent depression through epigenomic approach. Molecular psychiatry 28 (1) (2022)
Shinichiro Ochi, Yogesh Dwivedi
Dissecting early life stress-induced adolescent depression through epigenomic approach. Molecular psychiatry 28 (1) (2022)
Shinichiro Ochi, Yogesh Dwivedi
Dissecting early life stress-induced adolescent depression through epigenomic approach. Molecular psychiatry (2022)
Shinichiro Ochi, Yogesh Dwivedi
Dissecting early life stress-induced adolescent depression through epigenomic approach. Molecular psychiatry 28 (1) (2022)
Shinichiro Ochi, Yogesh Dwivedi
Dissecting early life stress-induced adolescent depression through epigenomic approach. Molecular psychiatry 28 (1) (2022)
Shinichiro Ochi, Yogesh Dwivedi
Dissecting early life stress-induced adolescent depression through epigenomic approach. Molecular psychiatry (2022)
Lauren A McKibben, Yogesh Dwivedi
Early-life stress induces genome-wide sex-dependent miRNA expression and correlation across limbic brain areas in rats. Epigenomics 13 (13) (2021)
Yuta Yoshino, Bhaskar Roy, Nilesh Kumar, M Shahid Mukhtar, Yogesh Dwivedi
Molecular pathology associated with altered synaptic transcriptome in the dorsolateral prefrontal cortex of depressed subjects. Translational psychiatry 11 (1) (2021)
Yuta Yoshino, Bhaskar Roy, Yogesh Dwivedi
Differential and unique patterns of synaptic miRNA expression in dorsolateral prefrontal cortex of depressed subjects. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 46 (5) (2020)
Matthew Timberlake Ii, Bhaskar Roy, Yogesh Dwivedi
A Novel Animal Model for Studying Depression Featuring the Induction of the Unfolded Protein Response in Hippocampus. Molecular neurobiology 56 (12) (2019)
Juhee Agrawal, Birgit Ludwig, Bhaskar Roy, Yogesh Dwivedi
Chronic Testosterone Increases Impulsivity and Influences the Transcriptional Activity of the Alpha-2A Adrenergic Receptor Signaling Pathway in Rat Brain. Molecular neurobiology 56 (6) (2018)
Birgit Ludwig, Bhaskar Roy, Yogesh Dwivedi
Role of HPA and the HPG Axis Interaction in Testosterone-Mediated Learned Helpless Behavior. Molecular neurobiology 56 (1) (2018)
Yogesh Dwivedi
microRNA-124: a putative therapeutic target and biomarker for major depression. Expert opinion on therapeutic targets 21 (7) (2017)